Trials / Unknown
UnknownNCT03256383
Plan for Testing Fingerstick Bloods on Magellan Systems
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 190 (estimated)
- Sponsor
- Magellan Diagnostics · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This study is to supplement our internal data that demonstrates the continued performance of capillary blood samples on Magellan's lead testing systems: LeadCare II, LeadCare Ultra (which have been cleared previously by FDA), and PediaStat, which is an upgraded LeadCare II instrument in development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Lead testing | Fingerstick |
Timeline
- Start date
- 2017-07-31
- Primary completion
- 2017-08-31
- Completion
- 2017-08-31
- First posted
- 2017-08-22
- Last updated
- 2017-08-22
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03256383. Inclusion in this directory is not an endorsement.